CA9 and breast neoplasm: Staining for pimonidazole (pimo), an established marker of hypoxia [32], in adjacent tissue sections mirrored the levels of expression of CAIX (Figure 2a,d), confirming that sunitinib results in increased hypoxia and a concomitant increase in the levels of expression of CAIX in both the early and later stages of breast tumor growth.